1Agarwal AK, Garg A. Congenital generalized lipodystrophy: significance of triglyceride biosynthetic pathways. Trends Endocrinol Metab, 2003,14:214-221. 被引量：1
2Agarwal AK, Simha V, Oral EA, et al. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy. J Clin Endocrinol Metab, 2003,88:4840-4847. 被引量：2
3Seip M, Trygstad O. Generalized lipodystrophy, congenital and acquired(lipoatrophy) .Acta Paediatr Suppl,1996,413:2-28. 被引量：1
4Simha V, Szczepaniak LS, Wagner AJ ,et al. Effect of leptin replacement on intrahepatic and intramyocellular lipid content in patients with generalized lipodystrophy. Diabetes Care,2003 ,26:30-35. 被引量：1
7Garg A, Wilson R, Barnes R, et al. A gene for congenital general- ized lipodystrophy maps to human chromosome 9q34. J Clin Endocrinol Metab, 1999,84(9):3390. 被引量：1
8Antuna-Puente B, Boutet E, Vigouroux C, et al. Higher adiponectin levels in patients with Berardinelli-Seip congenital lipodystrophy due to seipin as compared with 1-acylglycerol-3-
phosphate-o-acyltransferase-2 deficiency. J Clin Endocrinol Metab, 2010,95(3):1463. 被引量：1
9Beltrand J, Lahlou N, Le Charpentier T, et al. Resistance to leptin replacement therapy in Berardinelli-Seip congenital lipodystrophy (BSCL):An immunological origin. Eur J Endocrinol,2010:17. 被引量：1
